Clinical trial
Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
NCT00025272
Study timeline
Study start (actual)2001-11-01Date precision: day
Registry last updated2021-09-09
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Lung Cancerunresolved
Interventions
carboplatinDRUG · verified · RxNorm: carboplatin
etoposideDRUG · verified · RxNorm: etoposide
topotecan hydrochlorideDRUG · verified · RxNorm: topotecan hydrochloride
radiation therapyRADIATION
Sponsors & collaborators
Wake Forest University Health Scienceslead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00025272 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.